【発明の名称】核酸リガンドを用いる標的化合物の検出法

Title:

【発明の名称】核酸リガンドを用いる標的化合物の検出法

Document Type and Number:

Japanese Patent JP2000508169

Kind Code:

A

Abstract:

This invention discloses novel detection methods for determining the presence of a target compound in a substance using nucleic acid ligands as detection molecules. Specifically, the substance is bound to a solid support matrix, such as those used in blot procedures, and detection of the target molecule is accomplished using the affinity and specificity of nucleic acid ligands to the target molecule. The method utilized herein for identifying and preparing said nucleic acid ligands is called SELEX. The method of the present invention is additionally useful to isolate the target compounds from the various substances.

More Like This:

JP2006174740	DISEASE MARKER OF ALLERGIC DISEASE AND ITS USE
JP5950740	A nucleic acid amplification analysis device and the nucleic acid amplification analysis method
JP3370324	Description: Reconstituted human antibody against human interleukin-6 receptor

Inventors:

Drollet, Dan
Jaya Sena, Sumedha
Gold, rally

Application Number:

JP53628297A

Publication Date:

July 04, 2000

Filing Date:

March 28, 1997

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Nexter Pharmaceuticals, Inc.

International Classes:

C12N15/09; A61K31/70; C07H19/06; C07H19/10; C07H21/00; C07H21/02; C07H21/04; C07K5/00; C07K14/00; C12N9/12; C12N15/10; C12N15/115; C12P19/34; C12Q1/37; C12Q1/68; C12Q1/70; G01N33/531; G01N33/532; G01N33/535; G01N33/569; G01N33/68; G01N33/76; C07B61/00; F02B75/02; (IPC1-7): C12Q1/68

Attorney, Agent or Firm:

Akira Asamura (3 outside)

Previous Patent: 核酸分析のための方法

Next Patent: ＳＣＦ類似体組成物および方法